We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBTG:NYSEGlobal Business Travel Group, Inc. Analysis

Data as of 2026-08-31 - not real-time

$9.46

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $9.46, Global Business Travel Group, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. RSI sits at 57.3, which reads as neutral, and MACD momentum is bearish. Watch $9.42 as support and $9.52 as the nearer resistance level.
On valuation the read is overvalued — an earnings multiple of 59.1, absent a reliable peer benchmark. Consensus targets land 3.1% above where the shares trade now. Revenue is growing at 37.9% on a 2.8% profit margin.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 2.1%, a beta of 0.59 and a maximum drawdown of 40.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Global Business Travel Group, Inc. GBTG came out with quarterly earnings of $0.03 per share, missing the Zacks...Global Business Travel Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed...Business Wire1monGlobal Business Travel Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 7.73
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 7.73
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Revenue growth of +37.9%
  • P/E ratio of 59.1
  • Price-to-book of 3.01

Key Metrics & Analysis

Financial Health

Revenue Growth37.90%
Profit Margin2.77%
P/E Ratio59.1
ROE6.35%
ROA3.67%
Debt/Equity96.39
P/B Ratio3.0
Op. Cash Flow$250.0M
Free Cash Flow$425.9M

Technical Analysis

TrendBullish
RSI57.3
Support$9.42
Resistance$9.52
MA 20$9.45
MA 50$9.42
MA 200$7.73
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$26.17
Target Price$9.75
Upside/Downside3.07%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.59
Volatility2.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.